' Hypercoagulation, ' Antiphospholipid Antibodies Seen in COVID-19 ' Hypercoagulation, ' Antiphospholipid Antibodies Seen in COVID-19
Marked coagulopathy and presence of antiphospholipid antibodies and cerebral infarcts in patients with COVID-19 suggest the infection represents a ' hypercoagulable ' state, experts write.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news
More News: Antiphospholipid Syndrome | Brain | Cardiology | COVID-19 | Heart | Hughes Syndrome | Neurology | Neurosurgery